TWiV 870: COVID-19 clinical update #103 with Dr. Daniel Griffin

In COVID-19 clinical update #102, Daniel Griffin covers immunocompromised people, hospitalization of children, vaccine usage update, Omicron and cross-reactive neutralizing antibodies, reinfection prevents disease in hamsters, repeated infections with endemic coronaviruses, global burden of antimicrobial resistance, ivermectin not protective in hamsters, and Omicron evades therapeutic monoclonals. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode What does society owe immunocompromised people (Atlantic) Prevalence of immunosuppression in US (JAME) Hospitalizations of children (MMWR) Clinical considerations for vaccines (CDC) Sanofi seeks vaccine approval (Sanofi) Omicron triggers cross-reactive neutralization (medRxiv) Reinfection prevents disease in hamsters (Cell) Repeated infections with endemic CoV (J Inf Dis) Global burden of antimicrobial resistance (Lancet) Ivermectin not protective in hamsters (bioRxiv) Omicron evades therapeutic monoclonals (bioRxiv) Letters read on TWiV 870 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [e-mail]

Source: This Week in Virology - MP3 Edition - February 26, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts